Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) 50mg/200mg/25mg x 30 Tablets (Bictegravir 50mg, Emtricitabine 200mg and Tenofovir Alafenamide 25mg)

Biktarvy is a prescription medication used for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 25 kg. This combination therapy includes three active ingredients: bictegravir, emtricitabine, and tenofovir alafenamide, working synergistically to suppress HIV replication.

The formulation contains:

• Bictegravir - 50 mg: A potent integrase strand transfer inhibitor (INSTI) that blocks the integration of viral DNA into host cells.


• Emtricitabine - 200 mg: A nucleoside reverse transcriptase inhibitor (NRTI) that inhibits reverse transcription, preventing viral replication.


• Tenofovir Alafenamide - 25 mg: Another NRTI that is more effective and has a better safety profile compared to older formulations.

Biktarvy is taken once daily with or without food, providing convenience and adherence to treatment regimens. Its unique formulation is designed to minimize side effects while effectively managing HIV, making it a preferred choice for many patients.

Patients using Biktarvy should be monitored regularly for viral load and kidney function, as tenofovir can affect renal health. This medication is not recommended for individuals with severe renal impairment or those who are hypersensitive to its components.

Overall, Biktarvy represents a significant advancement in HIV treatment, offering an effective and well-tolerated option for maintaining viral suppression and improving the quality of life for those living with HIV.

• Bictegravir 50mg


• Emtricitabine 200mg


• Tenofovir Alafenamide 25mg

Biktarvy is a prescription medication used for the treatment of HIV-1 infection in adults and pediatric patients. To ensure safe and effective use of Biktarvy, follow these detailed instructions:

1. 
   

   Before starting Biktarvy, consult your healthcare provider to confirm that it is appropriate for your condition and to discuss any potential drug interactions or allergies you may have.

   
   


2. 
   

   Take Biktarvy exactly as prescribed by your healthcare provider. It is typically taken once daily, with or without food.

   
   


3. 
   

   Swallow the tablet whole. Do not chew, crush, or split the tablet, as this may affect how the medication is absorbed by your body.

   
   


4. 
   

   If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time.

   
   


5. 
   

   Keep track of your medication schedule and set reminders if necessary to ensure you do not miss a dose.

   
   


6. 
   

   Store Biktarvy at room temperature, away from moisture and heat. Keep it out of reach of children and pets.

   
   


7. 
   

   Regularly visit your healthcare provider for check-ups and lab tests to monitor your condition and the effectiveness of the medication.

   
   


8. 
   

   Be aware of potential side effects, including nausea, diarrhea, fatigue, or headache. Contact your healthcare provider if you experience severe or persistent side effects.

   
   


9. 
   

   Do not stop taking Biktarvy without consulting your healthcare provider, as this may lead to an increase in viral load and resistance to treatment.

   
   


10. 
    

    Inform your healthcare provider about any other medications, supplements, or herbal products you are taking to avoid potential interactions.

    
    

By following these instructions, you can help ensure the effectiveness of Biktarvy in managing your HIV-1 infection. Always prioritize open communication with your healthcare provider throughout your treatment journey.